| A clinically applicable molecular-based classification for endometrial cancers A Talhouk, MK McConechy, S Leung, HH Li-Chang, JS Kwon, N Melnyk, ... British journal of cancer 113 (2), 299-310, 2015 | 819 | 2015 |
| Confirmation of ProMisE: a simple, genomics‐based clinical classifier for endometrial cancer A Talhouk, MK McConechy, S Leung, W Yang, A Lum, J Senz, N Boyd, ... Cancer 123 (5), 802-813, 2017 | 785 | 2017 |
| Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond S Hansford, P Kaurah, H Li-Chang, M Woo, J Senz, H Pinheiro, ... JAMA oncology 1 (1), 23-32, 2015 | 755 | 2015 |
| Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series S Kommoss, MK McConechy, F Kommoss, S Leung, A Bunz, J Magrill, ... Annals of Oncology 29 (5), 1180-1188, 2018 | 590 | 2018 |
| New classification of endometrial cancers: the development and potential applications of genomic-based classification in research and clinical care A Talhouk, JN McAlpine Gynecologic oncology research and practice 3, 1-12, 2016 | 233 | 2016 |
| Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: earlier prognostic information to guide treatment A Talhouk, LN Hoang, MK McConechy, Q Nakonechny, J Leo, A Cheng, ... Gynecologic oncology 143 (1), 46-53, 2016 | 226 | 2016 |
| Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas MK McConechy, A Talhouk, HH Li-Chang, S Leung, DG Huntsman, ... Gynecologic oncology 137 (2), 306-310, 2015 | 213 | 2015 |
| Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis MK McConechy, A Talhouk, S Leung, D Chiu, W Yang, J Senz, ... Clinical Cancer Research 22 (12), 2865-2873, 2016 | 199 | 2016 |
| Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy CS Lo, S Sanii, DR Kroeger, K Milne, A Talhouk, DS Chiu, K Rahimi, ... Clinical Cancer Research 23 (4), 925-934, 2017 | 175 | 2017 |
| Molecular subtype not immune response drives outcomes in endometrial carcinoma A Talhouk, H Derocher, P Schmidt, S Leung, K Milne, CB Gilks, ... Clinical Cancer Research 25 (8), 2537-2548, 2019 | 126 | 2019 |
| Interobserver agreement in endometrial carcinoma histotype diagnosis varies depending on The Cancer Genome Atlas (TCGA)-based molecular subgroup LN Hoang, MA Kinloch, JM Leo, K Grondin, CH Lee, C Ewanowich, ... The American journal of surgical pathology 41 (2), 245-252, 2017 | 118 | 2017 |
| Prognostic gene expression signature for high-grade serous ovarian cancer J Millstein, T Budden, EL Goode, MS Anglesio, A Talhouk, ... Annals of Oncology 31 (9), 1240-1250, 2020 | 116 | 2020 |
| L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile FKF Kommoss, AN Karnezis, F Kommoss, A Talhouk, FA Taran, ... British journal of cancer 119 (4), 480-486, 2018 | 116 | 2018 |
| Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta‐analysis JN McAlpine, DS Chiu, RA Nout, DN Church, P Schmidt, S Lam, S Leung, ... Cancer 127 (14), 2409-2422, 2021 | 114 | 2021 |
| Evaluation of endometrial carcinoma prognostic immunohistochemistry markers in the context of molecular classification AN Karnezis, S Leung, J Magrill, MK McConechy, W Yang, C Chow, ... The Journal of Pathology: Clinical Research 3 (4), 279-293, 2017 | 97 | 2017 |
| Human papillomavirus (HPV)‐independent vulvar squamous cell carcinoma has a worse prognosis than HPV‐associated disease: a retrospective cohort study JN McAlpine, SCY Leung, A Cheng, D Miller, A Talhouk, CB Gilks, ... Histopathology 71 (2), 238-246, 2017 | 94 | 2017 |
| Molecular classification defines outcomes and opportunities in young women with endometrial carcinoma H Britton, L Huang, A Lum, S Leung, K Shum, M Kale, A Burleigh, J Senz, ... Gynecologic Oncology 153 (3), 487-495, 2019 | 93 | 2019 |
| Synthesis of diagnostic quality cancer pathology images by generative adversarial networks AB Levine, J Peng, D Farnell, M Nursey, Y Wang, JR Naso, H Ren, ... The Journal of pathology 252 (2), 178-188, 2020 | 91 | 2020 |
| Outcomes from opportunistic salpingectomy for ovarian cancer prevention GE Hanley, CL Pearce, A Talhouk, JS Kwon, SJ Finlayson, JN McAlpine, ... JAMA network open 5 (2), e2147343-e2147343, 2022 | 84 | 2022 |
| Morphologic and molecular characteristics of mixed epithelial ovarian cancers R Mackenzie, A Talhouk, S Eshragh, S Lau, D Cheung, C Chow, N Le, ... The American journal of surgical pathology 39 (11), 1548-1557, 2015 | 82 | 2015 |
Jessica N McALpineUniversity of British Columbia and BC Cancer AgencyVerified email at vch.ca
